A Clinical Trial of Telehealth Treatment for Opioid Use Disorders

Starting soon · Not applicable

Conditions studied: Opioid Use Disorder

In brief

This trial will assess effects of enrollment in a comprehensive telehealth platform, RecoveryPad (RP), in adults with moderate or severe opioid use disorder.

Key facts

Study ID

NCT07362082

Run by

Yale University

People needed

470

Starts

2026-08-15

Expected to finish

2027-12-01

Last updated by the study team

2026-07-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Can speak, read and write in English
• Provision of signed and dated informed consent form
• Screened positive for OUD, moderate or severe, based on the Diagnostic and Statistical Manual-5th Edition
• Have a working cell phone number and working device that can access a web browser and receive texts (i.e., smartphone, tablet or computer)
• Can provide a working email address OR be willing to create one

You may not qualify if…

• Current use of buprenorphine, methadone, or naltrexone for a substance use disorder
• Pregnancy
• Known current suicide risk based on participant self-report
• On parole or incarcerated at time of enrollment based on participant self-report

Where it is running

• Yale University — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.